Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease)

To assess the therapeutic activity of accelerated cisplatin and high-dose epirubicin with erythropoietin and G-CSF support as induction therapy for patients with stage IIIa-N2 non-small-cell lung cancer (NSCLC). Patients with stage IIIa-N2 NSCLC were enrolled in a phase II trial. They received cispl...

Descripción completa

Detalles Bibliográficos
Autores principales: Phernambucq, E C J, Biesma, B, Smit, E F, Paul, M A, Tol, A vd, Schramel, F M, Bolhuis, R J, Postmus, P E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360660/
https://www.ncbi.nlm.nih.gov/pubmed/16909132
http://dx.doi.org/10.1038/sj.bjc.6603289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360660/
https://www.ncbi.nlm.nih.gov/pubmed/16909132
http://dx.doi.org/10.1038/sj.bjc.6603289

Ejemplares similares